StreetInsider.com News Articles

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Harsch Mutya

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814193.html

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Harsch Mutya

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814193.html

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Domzalski David

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814194.html

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Domzalski David

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814194.html

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Stuart Iain

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814196.html

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Stuart Iain

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814196.html

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Zeronda Tyler

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814198.html

Form 4 VYNE Therapeutics Inc. For: Jul 23 Filed by: Zeronda Tyler

Fri, 24 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260724/26814198.html

VYNE Therapeutics distributes cash dividend ahead of Yarrow merger close

Thu, 23 Jul 2026 16:26:56 -0400

VYNE Therapeutics Inc. (Nasdaq: VYNE) distributed a special cash dividend on July 23, 2026, to stockholders of record as of July 22, 2026, ahead of its planned merger with Yarrow Bioscience, Inc.

The dividend was declared under the terms of a merger agreement signed December 17, 2025, with Yarrow and Yellow Merger Sub Corp. Because the cash dividend per share exceeded 25% of VYNE's stock price on the declaration date, Nasdaq set July 24, 2026, as the ex-dividend date.

Trades executed during the due bill period, which began July 21, 2026, and ran through the July 23 payment date, carry an obligation

VYNE Therapeutics distributes cash dividend ahead of Yarrow merger close

Thu, 23 Jul 2026 16:26:56 -0400

VYNE Therapeutics Inc. (Nasdaq: VYNE) distributed a special cash dividend on July 23, 2026, to stockholders of record as of July 22, 2026, ahead of its planned merger with Yarrow Bioscience, Inc.

Trades executed during the due bill period, which began July 21, 2026, and ran through the July 23 payment date, carry an obligation

VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

Thu, 23 Jul 2026 16:26:00 -0400

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its previously announced special cash dividend (the “Cash Dividend”), declared in connection with the terms and conditions of the Agreement and Plan of Merger and Reorganization, entered into on December 17, 2025, as amended (the “Merger Agreement”), with Yarrow Bioscience, Inc. (“Yarrow”) and Yellow Merger Sub Corp., was distributed, in cash, on July 23, 2026 to VYNE’s stockholders of record as of July 22, 2026 (the “Record Date”), subject to the Nasdaq due bill procedures described below, based

VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

Thu, 23 Jul 2026 16:26:00 -0400

VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

Thu, 23 Jul 2026 16:26:00 -0400

VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

Thu, 23 Jul 2026 16:26:00 -0400

Form 8-K VYNE Therapeutics Inc. For: Jul 21

Tue, 21 Jul 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260721/26792668.html

Form 8-K VYNE Therapeutics Inc. For: Jul 21

Tue, 21 Jul 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260721/26792668.html

VYNE Therapeutics sets 1-for-50 reverse split ahead of Yarrow merger

Tue, 21 Jul 2026 08:00:54 -0400

VYNE Therapeutics Inc. (Nasdaq: VYNE) announced that its board of directors has approved a 1-for-50 reverse stock split of its common stock in connection with its planned merger with Yarrow Bioscience, Inc.

The reverse stock split was approved by VYNE stockholders at a special meeting held July 16, 2026. Following the merger close, the combined company's stock is expected to begin trading on the Nasdaq Capital Market on July 27, 2026, under the name Yarrow Bioscience, Inc., with the ticker symbol "YARW".

The reverse split is expected to reduce VYNE's outstanding shares from approximately 33.4 million to approximately 0.7 million. The number

VYNE Therapeutics sets 1-for-50 reverse split ahead of Yarrow merger

Tue, 21 Jul 2026 08:00:54 -0400

The reverse split is expected to reduce VYNE's outstanding shares from approximately 33.4 million to approximately 0.7 million. The number

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Tue, 21 Jul 2026 08:00:00 -0400

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of VYNE’s common stock at a ratio of 1-for-50 in connection with the anticipated closing of the proposed merger (the “Merger”) with Yarrow Bioscience, Inc. (“Yarrow”). The reverse stock split was previously approved by VYNE’s stockholders at VYNE’s special meeting in lieu of the annual meeting of stockholders held on July 16, 2026 (the “Special Meeting”). Following the Merger, the combined company’s common stock is expected to begin

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Tue, 21 Jul 2026 08:00:00 -0400

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Tue, 21 Jul 2026 08:00:00 -0400

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Tue, 21 Jul 2026 08:00:00 -0400

Form 8-K VYNE Therapeutics Inc. For: Jul 16

Mon, 20 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260720/26786483.html

Form 8-K VYNE Therapeutics Inc. For: Jul 16

Mon, 20 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260720/26786483.html

Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: Zhang Xiaofan

Fri, 17 Jul 2026 09:54:00 -0400

si-local-file:///var/storage/secattach/20260717/26782637.html